
Congrats to @SharonCastelli2 and coauthors on this!
NEJM@NEJM
In the S1826 trial, researchers assessed the efficacy and safety of nivolumab plus chemotherapy with doxorubicin, vinblastine, and dacarbazine, as compared with brentuximab vedotin plus AVD, in patients with newly diagnosed classic Hodgkin’s lymphoma. nej.md/3A00MYS
English



















